3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
20
Glioblastoma
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Neoplasms
3
Leukoplakia, Oral
3
Insulin Resistance
3
Ovarian Neoplasms
2
Obesity
2
Metabolic Syndrome
2
Metabolic Diseases
2
Medulloblastoma
2
Infertility
2
Erythroplasia
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Adenocarcinoma Of Esophagus
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Thyroid Diseases
1
TP53 Y220C Mutation
1
Smoldering Multiple Myeloma
1
Sarcoma
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Prediabetic State
1
Posterior Fossa Ependymal Tumor
1
Interventions
Transcranial Direct Current Stimulation
2
Exercise
2
mazdutide
1
lime
1
fasudil
1
enzalutamide
1
Time
1
Tablets
1
Standard of Care
1
Referral and Consultation
1
Ramipril
1
Radiosurgery
1
Prednisone
1
Population Groups
1
Palliative Care
1
Organization and Administration
1
Modafinil
1
Methods
1
Metformin
1
Mental Status and Dementia Tests
1
Memantine
1
Low-Level Light Therapy
1
Hormones
1
Health
1
Gonadotropin-Releasing Hormone
1
Electroencephalography
1
Drug Delivery Systems
1
Data Collection
1
Anesthesia, General
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cognitive Dysfunction
×
Metformin
×
1 year
×
Clear all
NCT05230758
2026-05-01
Met Med Can
The Hospital for Sick Children
Phase 3
Recruiting
140 enrolled